2023-12-01 07:55:00
What remains of the unprecedented production effort launched during the Covid-19 pandemic? In 2021, CDMOs benefited from an unprecedented spotlight during the health crisis, with the production of the mRNA vaccine. Two years later, the record volumes requested to cope with the massive vaccination campaigns fizzled out. And push subcontractors to adapt.
Latest to date, Recipharm announced the cessation of its activities at its Monts site, in Indre-et-Loire, from the second quarter of 2025. Belonging to the Swedish group since 2007, the site employs 225 people and specializes in THE fill & finishi.e. filling operations, in aseptic conditions.
[…]
This article is reserved for our Industrie Pharma and Usine Nouvelle subscribers
Support expert journalism.
Log in
Selected for you
1701646310
#CDMOs #collateral #victims #disaffection #Covid19 #vaccine